Clinical Trial: VGN-Ex05e in Patients With Autism Spectrum Disorder Associated With Severe Self-Injurious and Aggressive Behaviors

U.S., Feb. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07433517) titled 'VGN-Ex05e in Patients With Autism Spectrum Disorder Associated With Severe Self-Injurious and Aggressive Behaviors' on Feb. 11.

Brief Summary: To evaluate the safety and tolerability of intracerebral injection of VGN-Ex05e in the nucleus accumbens of patients with autism spectrum disorder.

Study Start Date: April, 2026

Study Type: INTERVENTIONAL

Condition: Autism Spectrum Disorder

Intervention: BIOLOGICAL: VGN-Ex05e

Products derived from human embryonic stem cells for the treatment of allogeneic nerve cells

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Shanghai Jiao Tong University School of Medicine

Information provided...